Ποια είναι η τιμή για Poolbeg Pharma PLC (POLB)

Η τιμή για Poolbeg Pharma PLC (POLB) είναι $0.11565963

Ποια είναι η κεφαλαιοποίηση αγοράς για Poolbeg Pharma PLC (POLB)

Η κεφαλαιοποίηση αγοράς για Poolbeg Pharma PLC (POLB) είναι $882.99K

Poolbeg Pharma PLC (POLB) Τιμή και Κεφαλαιοποίηση Αγοράς

Poolbeg Pharma plc is a clinical-stage biopharmaceutical company based in the United Kingdom, focused on developing treatments for infectious diseases. Its pipeline features several key programs: POLB 001, a p38 MAP Kinase inhibitor intended for severe influenza; POLB 002, a pioneering, in-licensed RNA-based immunotherapy administered intranasally to combat respiratory virus infections; and POLB 003, an intramuscular vaccine aimed at preventing Melioidosis. Beyond specific therapeutic candidates, Poolbeg also holds licensed access to advanced micro- and nanoencapsulation technology for an oral vaccine delivery system designed to stimulate gut immunity. The company further advances its research through an artificial intelligence-powered drug program. Additionally, Poolbeg is developing a biomarker platform to identify individuals at high risk of severe disease, alongside a model-derived vaccine discovery platform to pinpoint novel vaccine candidates. Incorporated in 2021, Poolbeg Pharma plc is headquartered in London.

Η τιμή για POLB	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$714,304 $882.99K	NVDA	$5.453T	+617,591,455.16%
$587,248 $882.99K	AAPL	$4.483T	+507,738,036.93%
$545,096 $882.99K	GOOG	$4.161T	+471,292,844.65%
$482,915 $882.99K	MSFT	$3.687T	+417,530,730.81%
$371,295 $882.99K	AMZN	$2.835T	+321,023,788.21%

Η τιμή για POLB

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$714,304 $882.99K